Randomised consent designs in cancer clinical trials

D G Altman(The Honourable Society of Lincoln's Inn), David Machin(National Medical Research Council), Mahesh Parmar(University College London), SP Stenning, Peter Fayers(University of Aberdeen), John Whitehead(Lancaster City Council)

European Journal of Cancer

November 1, 1995

10.1016/0959-8049(95)00470-x

Cited by 65

Related Papers

EORTC QLQ-C30 Scoring Manual

|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

|The Lancet|2015|2k

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

|New England Journal of Medicine|2017|1.8k

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial

|The Lancet|2009|1.5k

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

|New England Journal of Medicine|1986|1.5k